Yating Chang

Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade

N. Xia, Jun Zhang, Wen-xin Luo, 2022, Journal for ImmunoTherapy of Cancer.

Intratumoral Delivery of a PD-1–Blocking scFv Encoded in Oncolytic HSV-1 Promotes Antitumor Immunity and Synergizes with TIGIT Blockade

N. Xia, Jun Zhang, Yingbin Wang, 2020, Cancer immunology research.

A potent neutralizing and protective antibody against a conserved continuous epitope on HSV glycoprotein D.

Min Zhao, Chenghao Huang, Y. Qin, 2022, Antiviral research.

Pharmaceutical targeting of OTUB2 sensitizes tumors to cytotoxic T cells via degradation of PD-L1

Chenghao Huang, Chaolong Lin, Fei Ju, 2024, Nature communications.